IOTN Moonshot (@iotnmoonshot) 's Twitter Profile
IOTN Moonshot

@iotnmoonshot

Official X account of the NCI Immuno-Oncology Translational Network (IOTN).

ID: 1047203297784938496

linkhttps://www.iotnmoonshot.org calendar_today02-10-2018 19:14:57

979 Tweet

1,1K Followers

186 Following

Science Immunology (@sciimmunology) 's Twitter Profile Photo

Scientists have found that tumor necrosis factor can switch macrophage #efferocytosis from immunologically silent to pro-inflammatory during #sepsis and systemic inflammation. Poltorak Lab Learn more in Science #Immunology: scim.ag/45Yvj6Y

Scientists have found that tumor necrosis factor can switch macrophage #efferocytosis from immunologically silent to pro-inflammatory during #sepsis and systemic inflammation. <a href="/LabPoltorak/">Poltorak Lab</a> 

Learn more in Science #Immunology: scim.ag/45Yvj6Y
Nature Reviews Cancer (@naturerevcancer) 's Twitter Profile Photo

In our June issue.... Emerling and colleagues summarize the roles of PI4Ks & PIPKs in cancer. They highlight the altered expression of these kinases in tumours & discuss ongoing efforts in developing therapies targeting lesser-studied PIPs. bit.ly/3Gjg2Df

Immunity (@immunitycp) 's Twitter Profile Photo

Online now: Prolonged but finite antigen presentation promotes reversible defects of “helpless” memory CD8+ T cells dlvr.it/TLYTLQ

IOTN Moonshot (@iotnmoonshot) 's Twitter Profile Photo

If you use Spearman (or Pearson) correlation p-values from standard software… there's a 99.9% chance they’re wrong. Drs. Han Yu and Alan Hutson oldbiostats of Roswell Park reveal why in "A robust Spearman correlation coefficient permutation test" , the top-cited article of the

Nature Reviews Cancer (@naturerevcancer) 's Twitter Profile Photo

Our July issue is LIVE! 🌞🥵🏖️ It features articles on: - Targeted protein degradation for cancer therapy - Advances in therapeutic cancer vaccines - The TGFβ paradox in HPV-driven cancer - The paths to metastasis Happy reading! 👇 📖 bit.ly/3I1QUla

Our July issue is LIVE!  🌞🥵🏖️ 

It features articles on:
- Targeted protein degradation for cancer therapy
- Advances in therapeutic cancer vaccines
- The TGFβ paradox in HPV-driven cancer
- The paths to metastasis 

Happy reading!  👇  📖 
bit.ly/3I1QUla
Cancer Cell (@cancer_cell) 's Twitter Profile Photo

Online Now: A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesis dlvr.it/TLbxFY

Online Now: A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesis dlvr.it/TLbxFY
Nature Cancer (@naturecancer) 's Twitter Profile Photo

📢New Article published Nature Cancer ! 'Innate immunity and the NF-κB pathway control prostate stem cell plasticity, reprogramming and tumor initiation' ✒️By Cédric Blanpain and colleagues 🔗nature.com/articles/s4301…

Nature Cancer (@naturecancer) 's Twitter Profile Photo

🚨Read this REVIEW published Nature Cancer ! 'The tumor microenvironment’s role in the response to immune checkpoint blockade' ✏️By Vassiliki Boussiotis and co-authors 🔗nature.com/articles/s4301…

Nature Cancer (@naturecancer) 's Twitter Profile Photo

📢Another REVIEW now ONLINE @Naturecancer 'Advancing therapeutics in small-cell lung cancer' ✒️By Anish Thomas, Chirayu Mohindroo & Giuseppe Giaccone 🔗nature.com/articles/s4301…

Nature Reviews Cancer (@naturerevcancer) 's Twitter Profile Photo

Perspective 🚨 Orsolya Vincze @OVincze, Thomas Pradeu &Co discuss how cancer research can be advanced using comparative oncology and call for the increased use of non-conventional model organisms to advance cancer prevention and treatment. 📖 ⬇️ bit.ly/3U0oIBD

Society for Immunotherapy of Cancer (@sitcancer) 's Twitter Profile Photo

Attend tomorrow's webinar on Predicting Patients' Response to Immunotherapy from Tumor Histopathology and Blood! This webinar will describe 4 approaches for predicting patients’ response to checkpoint immunotherapy! Learn more about this series & register: sitcancer.org/CompIO

Attend tomorrow's webinar on Predicting Patients' Response to Immunotherapy from Tumor Histopathology and Blood! This webinar will describe 4 approaches for predicting patients’ response to checkpoint immunotherapy! Learn more about this series &amp; register: sitcancer.org/CompIO
CAP-IT (@ncicapit) 's Twitter Profile Photo

Don't wait-register now for the CAP-IT Virtual Annual Summit on July 24, 2025! Open to the public with exciting talks on cancer prevention and interception. 🔗 Register: tinyurl.run/M3wsBV ℹ️ Info: NCICAPIT.org 📧 [email protected] #CancerPrevention #NCICAPIT

Don't wait-register now for the CAP-IT Virtual Annual Summit on July 24, 2025! 
Open to the public with exciting talks on cancer prevention and interception.
🔗 Register: tinyurl.run/M3wsBV
ℹ️ Info: NCICAPIT.org
📧 CAP-IT@nih.gov
#CancerPrevention #NCICAPIT
Science Immunology (@sciimmunology) 's Twitter Profile Photo

Scientists show that paired analysis of #CD69 mRNA and protein levels can help identify potent CD8 T cells with enhanced #cytotoxic effector functions within exhausted populations in tumors. Arja Ray Max Learn more in Science #Immunology: scim.ag/3Ik4aBL

Scientists show that paired analysis of #CD69 mRNA and protein levels can help identify potent CD8 T cells with enhanced #cytotoxic effector functions within exhausted populations in tumors. <a href="/RayArja/">Arja Ray</a> <a href="/MaxKrummel/">Max</a>

Learn more in Science #Immunology: scim.ag/3Ik4aBL
Cancer Cell (@cancer_cell) 's Twitter Profile Photo

The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets dlvr.it/TLyB5j

The pan-cancer proteome atlas, a mass spectrometry-based landscape for discovering tumor biology, biomarkers, and therapeutic targets dlvr.it/TLyB5j
Journal for ImmunoTherapy of Cancer (@jitcancer) 's Twitter Profile Photo

New #JITC article: Therapeutic potential of T-cell receptor targeting the HLA-A*11:01-restricted KRASG12V neoantigen without cross-recognition of the self-antigen RAB7B in solid tumors bit.ly/44IMZ5H

New #JITC article: Therapeutic potential of T-cell receptor targeting the HLA-A*11:01-restricted KRASG12V neoantigen without cross-recognition of the self-antigen RAB7B in solid tumors bit.ly/44IMZ5H